Centrus is the only listed U.S. supplier of enriched uranium, with a $3.6B backlog and $833M cash, giving visibility and financing flexibility. Revenue fell to $154.5M (down $34.5M YoY) due to lower SWU sales, but gross margin jumped to 35% and net income held steady at $28.9M. $60M investment in supply chain readiness, DOE contract extension for HALEU through 2026 (with option to 2034), and nearly one ton of HALEU already produced.
LEU's weak uranium sales drag Q2 results, but a $3.6B backlog underscores long-term strength despite near-term headwinds.
LEU surges 12% post-earnings as strong HALEU progress offsets concerns over year-over-year revenue and EPS declines.
Centrus Energy Corp. (NYSE:LEU ) Q2 2025 Earnings Conference Call August 6, 2025 8:30 AM ET Company Participants Amir V. Vexler - President, CEO & Director Kevin J.
Centrus Energy Corp. (LEU) came out with quarterly earnings of $1.59 per share, beating the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $1.89 per share a year ago.
Centrus Energy (LEU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Centrus Energy boasts HALEU leadership and soaring sales; NexGen Energy holds a high-grade asset poised to reshape uranium production.
LEU revenues soars 67% in Q1 2025 as SWU prices and volumes surged; HALEU momentum and backlog point to strong tailwinds ahead.
LEU soars 197% year to date as it advances HALEU production, books a $3.8B backlog and rides strong Q1 results.
LEU completes Phase II HALEU delivery to DOE, secures contract extension and eyes major growth in U.S. uranium market.
Centrus Energy hits a major milestone with 900 kg HALEU delivery to the Department of Energy, advancing its role in the U.S. advanced reactor fuel supply.
LEU edges ahead of SMR with strong HALEU demand, DOE support, and superior earnings potential despite sector growth for both.